Thermo Fisher secures EUA for 2 new COVID-19 tests

2021 04 27 22 24 2298 Nasal Swab Test 400

The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Thermo Fisher Scientific for two new COVID-19 tests, TaqPath COVID-19 Fast PCR Combo Kit 2.0 and TaqPath COVID-19 RNase P Combo Kit 2.0.

The Thermo Fisher tests are intended to address emerging mutations and variants, the company said. Both target eight genes across three regions of SARS-CoV-2.

TaqPath COVID-19 Fast PCR Combo Kit 2.0 tests saliva samples, while TaqPath COVID-19 RNase P Combo Kit 2.0 tests nasal samples, according to Thermo Fisher.

Page 1 of 27
Next Page